Search - tctmd.com

Displaying 1 - 20 of 76

Sort: Relevancy | Date

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Caitlin E. Cox

October 21, 2025

News Conference News ESC 2025

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Caitlin E. Cox

September 08, 2025

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

L.A. McKeown

June 05, 2025

News Conference News EuroPCR 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Yael L. Maxwell

May 20, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Presenter: Maryjane Farr

March 05, 2024

Presentation THT Abstracts 2024

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Presenter: McKenzie Sicke

March 04, 2024

Advertisement

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

ACC/AHA Release New Comprehensive ACS Guidelines

Experts Hash Out Recommendations for Impella CP After DanGer Shock

January 2025 Dispatch for the CV Team

Top Coronary Artery Disease News in 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content